The Gross Margin of Atara Biotherapeutics Inc (ATRA) is 82.44%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2025-12-31 | 82.44% |
| 2024-12-31 | 83.71% |
| 2023-12-31 | -3.65% |